An analysis of the effects of regular almond consumption on lipid profiles of adults across different BMI categories
Effects of almond consumption on lipid profiles
DOI:
https://doi.org/10.52442/jrmi.v11i1.674Keywords:
Almonds, BMI, Cholesterol, Lipid Profile, Obesity, OverweightAbstract
Introduction: Obesity is associated with a variety of cardiometabolic complications, including hypertension, dyslipidemia, and hyperglycemia. The daily consumption of almonds has been previously associated with improving lipid levels in individuals at risk of cardiovascular diseases.
Objectives: To assess the impact of almond consumption on the serum lipid profile of normal-weight, overweight, and obese individuals and to determine which group experiences the greatest advantages.
Materials and Methods: A quasi-experimental study was conducted at Central Park Medical College Lahore, from September 2023 to February 2024. The study recruited a total of 90 adult male and female subjects, with an age range of 21 to 60 years without having any gastric, renal, or hepatic disease. They were divided into normal (Group 1), overweight (Group 2), and obese (Group 3) categories, based on Body Mass Index (BMI). Blood samples were collected from each subject during the fasting stage. The subjects were subsequently instructed to ingest 50 g of almonds (without the rind) daily for 30 days. Lipid profile analysis was conducted both before and after supplementation and analyzed using SPSS version 23.
Results: Group 1 showed decreased cholesterol (p=0.001), low-density lipoproteins (p=0.001), and very low-density lipoproteins (p=0.004), respectively. In Group 2, cholesterol levels were decreased (p=0.017) while in Group 3 there was no substantial change in lipid profiles (p>0.05) because of supplementation of almonds.
Conclusion: The positive impacts of almond intake on lipid profile are more distinct in normal-weight and overweight individuals as compared to obese individuals.
References
Asbaghi O, Moodi V, Hadi A, Eslampour E, Shirinbakhshmasoleh M, Ghaedi E, et al. The effect of almond intake on lipid profile: a systematic review and meta-analysis of randomized controlled trials. Food Funct. 2021;12(5):1882–1890. doi:10.1039/D0FO02878A.
Liu X, Hill AM, West SG, Gabauer RM, McCrea CE, Fleming JA, et al. A 12-week randomized controlled trial of almond consumption and cardiovascular risk factors in overweight and obese adults. J Am Heart Assoc. 2020;9(9):e015258. doi:10.1161/JAHA.119.015258.
Altamimi M, Zidan S, Badrasawi M. Effect of tree nuts consumption on serum lipid profile in hyperlipidemic individuals: a systematic review. Integr Food Nutr Metab. 2020;7:1–10. doi:10.1177/1178638820926521.
Jamshed H, Sultan FA, Iqbal R, Gilani AH. Almond supplementation reduces serum cholesterol in coronary artery disease patients: a randomized controlled trial. Nutr Metab Cardiovasc Dis. 2020;30(6):1040–1049. doi:10.1016/j.numecd.2020.02.007.
Coates AM, Hill AM, Tan SY, Buckley JD, Howe PR. Nuts and cardiovascular disease prevention. Curr Atheroscler Rep. 2020;22(11):61. doi:10.1007/s11883-020-00876-0.
Liu X, Hill AM, West SG, Gabauer RM, McCrea CE, Fleming JA, et al. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus: a randomized controlled trial. Nutrients. 2019;11(9):2065. doi:10.3390/nu11092065.
Berryman CE, West SG, Fleming JA, Bordi PL, Kris-Etherton PM. Effects of daily almond consumption on cardiometabolic risk and abdominal adiposity in healthy adults with elevated LDL-cholesterol: a randomized controlled trial. J Am Heart Assoc. 2015;4(1):e000993. doi:10.1161/JAHA.114.000993.
Katz DL, Davidhi A, Ma Y, Kavak Y, Bifulco L, Njike VY. Effects of walnuts on endothelial function in overweight adults with visceral obesity: a randomized, controlled, crossover trial. J Am Coll Nutr. 2012;31(6):415–423. doi:10.1080/07315724.2012.10720456.
Griel AE, Kris-Etherton PM. Tree nuts and the lipid profile: a review of clinical studies. Br J Nutr. 2006;96(Suppl 2):S68–S78. doi:10.1017/BJN20061864
Sabate J, Haddad E, Tanzman JS, Jambazian P, Rajaram S. Serum lipid response to the graduated enrichment of a Step I diet with almonds: a randomized feeding trial. Am J Clin Nutr. 2003;77(6):1379–1384. doi:10.1093/ajcn/77.6.13.
Hyson DA, Schneeman BO, Davis PA. Almonds and almond oil have similar effects on plasma lipids and LDL oxidation in healthy men and women. J Nutr. 2002;132(4):703–707. doi:10.1093/jn/132.4.703.
Abbey M, Noakes M, Belling GB, Nestel PJ. Partial replacement of saturated fatty acids with almonds or walnuts lowers total plasma cholesterol and low-density-lipoprotein cholesterol. Am J Clin Nutr. 1994;59(5):995–999. doi:10.1093/ajcn/59.5.9
Carroll MD, Kit BK, Lacher DA, Shero ST, Mussolino ME. Trends in lipid profiles of adults in the United States, 1988–2010. JAMA. 2012;308(15):1545–54. doi: 10.1001/jama.2012.13260.
Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. JACC. 2014;63(25PtB):2889–934. doi: 10.1016/j.jacc.2013.11.002.
World Health Organization. BMI classification. 2021. https://www.who.int/data/gho/data/themes/topics/topic-details/GHO/body-mass-index
Spiller GA, Jenkins DA, Bosello O, Berra K, Gates JE, Cragen LN, et al. Nuts and plasma lipids: an almond-based diet lowers LDL-C while preserving HDL-C. Arch Intern Med. 1998;158(9):969–973. doi:10.1001/archinte.158.9.96.
Jenkins DJ, Kendall CW, Marchie A, Josse AR, Nguyen TH, Faulkner DA, et al. Almonds reduce biomarkers of lipid peroxidation in older hyperlipidemic subjects. J Nutr. 2008;138(5):908–913. doi:10.1093/jn/138.5.908.
Rajaram S, Burke K, Connell B, Myint T, Sabate J. A monounsaturated fatty acid-rich pecan-enriched diet favorably alters the serum lipid profile of healthy men and women. J Nutr. 2001;131(9):2275–2279. doi:10.1093/jn/131.9.2275.
Fraser GE, Sabate J, Beeson WL, Strahan TM. A possible protective effect of nut consumption on risk of coronary heart disease: the Adventist Health Study. Arch Intern Med. 1992;152(7):1416–1424. doi:10.1001/archinte.1992.00400190045006.
Kris-Etherton PM, Zhao G, Binkoski AE, Coval SM, Etherton TD. The effects of nuts on coronary heart disease risk. Nutr Rev. 2001;59(4):103–111. doi:10.1111/j.1753-4887.2001.tb07001.x.
Ros E, Núñez I, Pérez-Heras A, Serra M, Gilabert R, Casals E, et al. A 6-month monounsaturated fat-rich diet supplemented with almonds improves plasma lipid profiles and reduces the risk of coronary heart disease. J Nutr. 2004;134(3):460–466. doi:10.1093/jn/134.3.460.
Berryman CE, West SG, Kris-Etherton PM. Effects of almonds on the lipid profile: a review of recent studies. J Am Coll Nutr. 2020;39(3):209–217. doi:10.1080/07315724.2019.1671030.
Abazarfard Z, Eslamian G, Salehi M, Keshavarzi S. A randomized controlled trial of the effects of an almond-enriched, hypocaloric diet on liver function tests in overweight/obese women. Iran Red Crescent Med J. 2016;18(3):e23628. doi:10.5812/ircmj.23628.
Dhillon J, Tan S, Mattes R. Almond consumption during energy restriction lowers truncal fat and blood pressure in compliant overweight or obese adults. J Nutr. 2019;146(12):2513–2519. doi:10.1093/jn/nxz179.
Kanwar G, Kabra R. A study of association between obesity and lipid profile. IJRNASS. 2016;4(4):69–74. doi:10.26480/ijrnass.04.2016.69.74.
Kelishadi R, Hashemipour M, Sheikh-Heidar A, Ghatreh-Samani S. Changes in serum lipid profile of obese or overweight children and adolescents following a lifestyle modification course. ARYA Atheroscler. 2022;8(3):143–148.
Wien MA, Sabaté MJ, Ikle ND, Cole ES, Kandeel RF. Almonds vs complex carbohydrates in a weight reduction program. Int J Obes. 2023;27(10):1365–1372. doi:10.1038/s41366-023-01034-1.
